Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Stricter Limits for Hydrocodone Pain Pills Backed by FDA Panel

Hydrocodone painkillers, the most popular pharmacy drugs in the U.S., should be placed under greater regulatory restrictions because of the potential for abuse, a panel of advisers to the Food and Drug Administration recommended.

The FDA should expand limits on hydrocodone-combination pills such as Vicodin as well as cough suppressants containing hydrocodone, the advisory committee voted 19-10 today to conclude a two-day meeting in Silver Spring, Maryland. The FDA, which in 2008 denied a request by the Drug Enforcement Administration for stricter regulation, must now decide whether to follow the panel’s recommendation.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.